Show
Sort by
-
- Journal Article
- A1
- open access
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
-
- Journal Article
- A1
- open access
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
-
- Journal Article
- A1
- open access
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
-
- Journal Article
- A1
- open access
Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores
-
- Journal Article
- A1
- open access
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
-
- Journal Article
- A1
- open access
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
-
- Journal Article
- A1
- open access
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
-
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
-
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants : results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
-
- Journal Article
- A1
- open access
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
-
- Journal Article
- A1
- open access
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
-
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
-
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
-
Height and body mass index as modifiers of breast cancer risk in BRCA1/2 mutation carriers : a Mendelian randomization study
-
- Journal Article
- A1
- open access
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
-
- Journal Article
- A1
- open access
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
-
- Journal Article
- A1
- open access
Shared heritability and functional enrichment across six solid cancers
-
A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk
-
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
-
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer
-
- Journal Article
- A1
- open access
Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
-
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
-
- Journal Article
- A1
- open access
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression : identification of a modifier of breast cancer risk at locus 11q22.3
-
- Journal Article
- A1
- open access
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
-
- Journal Article
- A1
- open access
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
-
- Journal Article
- A1
- open access
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
-
- Journal Article
- A1
- open access
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
-
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
-
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers
-
- Journal Article
- A1
- open access
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
-
- Journal Article
- A1
- open access
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
-
- Journal Article
- A1
- open access
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
-
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction